John A. Jakob, Ph.D.
Affiliations: | 2004 | Columbia University, New York, NY |
Area:
Genetics, OncologyGoogle:
"John Jakob"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ramon E. Parsons | grad student | 2004 | Columbia | |
| (Identification and characterization of a biallelic deletion in chromosome band 18q21.1 of human breast cancer cell line HCC-1428.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fang P, Boehling NS, Koay EJ, et al. (2017) Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. Journal of Neuro-Oncology |
| Jakob JA, Kies MS, Glisson BS, et al. (2015) Phase II study of gefitinib in patients with advanced salivary gland cancers. Head & Neck. 37: 644-9 |
| Bucheit AD, Syklawer E, Jakob JA, et al. (2013) Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer. 119: 3821-9 |
| Stockman D, Tetzlaff MT, Al-Zaid T, et al. (2013) Differential clinical associations of BRAF and NRAS mutations among histologic types of cutaneous melanomas. Journal of Clinical Oncology. 31 |
| Jakob JA, Bassett RL, Ng CS, et al. (2012) NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 118: 4014-23 |
| Koay EJ, Bucheit AD, Jakob JA, et al. (2012) Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. Journal of Clinical Oncology. 30: 8584-8584 |
| Jakob JA, Bassett RL, Ng CS, et al. (2011) Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8500 |
| Jakob J, Nagase S, Gazdar A, et al. (2005) Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line. Genes, Chromosomes & Cancer. 42: 372-83 |